Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenue	$ 5,069,416	$ 3,564
Cost of revenues	3,036	1,373
Gross margin	5,066,380	2,191
Selling, general and administrative expenses	2,180,067	929,069
Research and development	1,939,888	1,120,078
Operating income (loss)	946,425	(2,046,956)
Other income
Interest income, net	990	1,571
Net income (loss)	$ 947,415	$ (2,045,385)
Per share information
Net income (loss) - basic (in Dollars per share)	$ 0.09	$ (0.29)
Net income (loss) - diluted (in Dollars per share)	$ 0.07	$ (0.29)
Weighted average number of basic common shares outstanding (in Shares)	10,068,092	7,142,307
Weighted average number of diluted common shares outstanding (in Shares)	12,865,361	7,142,307